Anjon’s Novel  Cellular Protection Technology

  • Anjon technology uses a complex emollient that acts as an immune system stimulant and antioxidant specifically for skin cell wall protection.
  • Activated for the period of radiation exposure, using a deep tissue protection mechanism preventing skin  cell damage.
  • Anjon technology provides an open skin pore enhanced pass through environment reducing or eliminating  skin cell damage.
  • We expect our technology to significantly reduce the risk of skin cancer, it has been proven in testing to protect the skin from UVA and UVB radiation damage.

tube-arc-1

ARC™ for Radiation Dermatitis Treatment

  • ARC™ is an aqueous based topical cream for skin protection and  intervention of Radiation Dermatitis.
  • Formulated with a blend of a natural active ingredient and minerals that  act in tandem as catalysts for the protection of the DNA of individual  skin cells, preventing damage caused by radiation.
Indication(s) Radiation Dermatitis
Status & Timelines OTC Registered with 510k registration by end of 2016
Product USP(s) Ideal for all skin types. Has shown zero negative reactions

 


DermaPlus™ – A Multiplatform Topical Therapy

ulcer-before
ulcer-5days

Diabetic Leg Ulcer Treatment

  • DermaPlus is a Hydro Gel Emollient for control of topical bacterial infections, infected wounds, burns and ulcerated sores.
  • DermaPlus is a multiplatform antibacterial product that is adaptable to many target treatments. Has been successfully used a as primary wound care product for animals for the past five years.
Indication(s) Topical bacterial infections including impetigo and resistant bacteria strains such as MRSA

  • Diabetic Skin Ulcers – often infected with antibiotic resistant bacteria strains
  • HSV 2
  • Acne
  • Shingles
  • Pressure sores
  • Burns  resulting from radiation therapies and other sources
Status & Timelines Finished 5 years of animal testing, early stage
Product USP(s) Ideal for all skin types. Has shown zero negative reactions

Acne Treatment

acne1

  • Patient previously treated with Accutane
  • DermaPlus applied twice a day for 7 days

medimage1

The New Age of Disease Management

Antimicrobial Resistance Threatens Global Populations


World Health Organization (April 2015) – “Antimicrobial resistance for an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi is an increasingly serious threat to global public health that requires action across all government sectors and society.”

antibac-1

Antibacterial For the Treatment of Bacterial Infections

  • An antibacterial platform that has shown to effectively control infections including antibiotic resistant strains in animal testing.
  • Suited to either oral or intravenous application and is designed to stop bacterial infections.
  • A natural alternative substituting todays antibiotics
  • POC -The AB-100 will be registered as a new drug now entering PreIND (Investigative New Drug) testing.

antiviral1

Antiviral for the Treatment of Viral Diseases

  • An antiviral drug platform
  • Suited to either oral or intravenous application and is designed to stop the replication of the virus and allow natural death of the infected cells.
  • Offers an effective immunostimulant that encouragers increased t-cell production and an enhanced immune system response.

Cross platform technologies enhances market opportunities

graph1

Clinical Development Milestones

clinical1